Last reviewed · How we verify
NCT07202767
Intraocular Lens Calculation Using Artificial Intelligence
trial testing Swept-Source Anterior Segment OCT in Cataract in 170 participants. Not yet recruiting.
30 July 2027
Quick facts
| Lead sponsor | Johannes Kepler University of Linz |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 170 |
| Start date | 1 November 2025 |
| Primary completion | 30 July 2027 |
| Estimated completion | 30 October 2028 |
| Sites | 1 location across Austria |
Drugs / interventions tested
- Swept-Source Anterior Segment OCT
Conditions studied
- Cataract — all drugs for Cataract →
Sponsor
Johannes Kepler University of Linz
Who can join
21 and older, any sex, with Cataract. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the lens diameter (LD) as a useful parameter in intraocular lens (IOL) power calculation by using several different non-invasive imaging techniques. The aim is to establish an accurate model for lens diameter estimation and subsequently evaluate the influence of the LD on the effective postoperative lens position. The comparability of the different devices in terms of variability between the biometric measurements will also be assessed. By then combining these two approaches with artificial intelligence, the aim is to develop a new approach to effectively incorporate the LD in IOL power calculation and improve patient's outcome in the long run.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07202767
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cataract
Currently open trials in the same condition.
- NCT07301385 — Evaluation of Head-Mounted Spatial Computing and Three-Dimensional (3D) Visualization in Ocular Microsurgery: A Safety a · NA · recruiting
- NCT07462000 — Aqueous Humor and Ocular Tissue Analysis in Glaucoma and Cataract · NA · recruiting
- NCT06891092 — Vivinex Impress XY1-EM vs RayOne EMV · NA · recruiting
- NCT07218796 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
- NCT07218783 — Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compar · Phase 3 · recruiting
Other Johannes Kepler University of Linz trials
Trials by the same sponsor.
- NCT07210372 — Axial Stability in Short and Long Eyes After Cataract Surgery · completed
- NCT06595693 — Tilt Prediction of Clareon Intraocular Lens · completed
- NCT05719532 — Core Strength and Coordinative Skills · unknown
- NCT05769543 — WATSU and Body Awareness · NA · completed
- NCT05690893 — Crystalline Lens Tilt Evaluation Using Swept-source Optical Coherence Tomography · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07202767 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Johannes Kepler University of Linz
- Last refreshed: 2 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07202767.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing